4 Einträge gefunden

1. AXL Inhibition Represents a Novel Therapeutic Approach in BCR-ABL Negative Myeloproliferative Neoplasms

   1. Beitzen-Heineke, Antonia
   2. Berenbrok, Nikolaus
   3. Waizenegger, Jonas Siddhartha
   4. Päsler, Sarina
   5. Gensch, Victoria
   6. Udonta, Florian
   7. Vargas-Delgado, Maria Elena

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Axl Blockade by BGB324 Inhibits BCR-ABL Tyrosine Kinase Inhibitor-Sensitive and -Resistant Chronic Myeloid Leukemia

   1. Ben Batalla, Isabel
   2. Erdmann, Robert
   3. Jørgensen, Heather
   4. Mitchell, Rebecca
   5. Ernst, Thomas
   6. von Amsberg, Gunhild
   7. Schafhausen, Philippe

   2017 - Forschungsinformationssystem des UKE
3. Bosutinib.

   1. von Amsberg, Gunhild
   2. Schafhausen, Philippe
   3. Brümmendorf, Tim

   2010 - Forschungsinformationssystem des UKE
4. PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases.

   1. Gontarewicz, Artur
   2. Balabanov, Stefan
   3. von Amsberg, Gunhild
   4. Panse, Jens
   5. Schafhausen, Philippe
   6. Bokemeyer, Carsten
   7. Fiedler, Walter

   2008 - Forschungsinformationssystem des UKE